Wound Care (Pharmacies) - Bosnia and Herzegovina

  • Bosnia and Herzegovina
  • Revenue in the Wound Care market is projected to reach US$0.59m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.34%, resulting in a market volume of US$0.60m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.18 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Bosnia and Herzegovina is experiencing steady growth due to increasing customer demand for wound care products and the country's improving healthcare infrastructure.

Customer preferences:
Customers in Bosnia and Herzegovina have a growing preference for wound care products that are effective, easy to use, and affordable. They are increasingly seeking products that promote faster wound healing and provide pain relief. There is also a rising demand for wound care products that are suitable for different types of wounds, including cuts, burns, and ulcers. Customers are also looking for products that are easily accessible through pharmacies, as they trust the expertise and advice of pharmacists in recommending the right products for their specific wound care needs.

Trends in the market:
One of the key trends in the Wound Care (Pharmacies) market in Bosnia and Herzegovina is the increasing availability and variety of wound care products in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for wound care products, including bandages, dressings, antiseptics, and wound healing ointments. This trend is driven by the increasing awareness among customers about the importance of proper wound care and the availability of a wide range of wound care products in the market. Another trend in the market is the growing adoption of advanced wound care products. These products are designed to promote faster wound healing and reduce the risk of infection. Advanced wound care products include foam dressings, hydrocolloid dressings, and alginate dressings, among others. These products are gaining popularity among healthcare professionals and customers due to their effectiveness and ability to accelerate the healing process.

Local special circumstances:
Bosnia and Herzegovina has a well-established network of pharmacies, which play a crucial role in the distribution of wound care products. Pharmacies are easily accessible to customers in both urban and rural areas, ensuring that wound care products are readily available to those in need. The presence of pharmacists in pharmacies also allows for personalized advice and recommendations, which further enhances customer trust and satisfaction.

Underlying macroeconomic factors:
The growth of the Wound Care (Pharmacies) market in Bosnia and Herzegovina is supported by several macroeconomic factors. The country's improving healthcare infrastructure, including the expansion of healthcare facilities and the availability of healthcare professionals, has contributed to the increasing demand for wound care products. Additionally, the rising disposable income and improving living standards of the population have made wound care products more affordable and accessible to a larger customer base. The government's focus on healthcare development and investment in healthcare services has also played a significant role in driving the growth of the market. Overall, the Wound Care (Pharmacies) market in Bosnia and Herzegovina is witnessing positive growth due to increasing customer preferences for effective and affordable wound care products, the availability of a wide range of products in pharmacies, and the country's improving healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)